Bill Kerns, DVM, MS, DACVP
Partner
Chief Executive Officer

Regulatory & Drug Development
Pharmacology/Toxicology
Small Molecules/Proteins
Expedited Strategies to Phase 1
Broad IND to NDA Experience

Kei-Lai Fong, PhD
Partner
Executive Vice President

Preclinical-Clinical PK/PD
Biotransformation
Bioanalytical
Drug-Drug Interactions
Discovery thru Phase 3

Marc Cote
Partner
Chief Operating Officer

Financial Management
Business Development
Business Operations
Alliances & Partnerships
Start-up Support